Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype
- PMID: 29604251
- PMCID: PMC6153055
- DOI: 10.1016/j.jid.2018.03.1517
Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype
Abstract
Patients with atopic dermatitis (AD) are commonly colonized with Staphylococcus aureus (AD S. aureus+), but what differentiates this group from noncolonized AD patients (AD S. aureus-) has not been well studied. To evaluate whether these two groups have unique phenotypic or endotypic features, we performed a multicenter, cross-sectional study enrolling AD S. aureus+ (n = 51) and AD S. aureus- (n = 45) participants defined by the presence or absence of S. aureus by routine culture techniques and nonatopic, noncolonized control individuals (NA S. aureus-) (n = 46). Filaggrin (FLG) genotypes were determined, and disease severity (Eczema Area and Severity Index, Rajka-Langeland Severity Score, Investigator's Global Assessment score, Numerical Rating Scale, and Dermatology Life Quality Index) was captured. Skin physiology was assessed (transepidermal water loss [TEWL], stratum corneum integrity, hydration, and pH), and serum biomarkers were also measured. We found that AD S. aureus+ patients had more severe disease based on all scoring systems except itch (Numerical Rating Scale), and they had higher levels of type 2 biomarkers (eosinophil count, tIgE, CCL17, and periostin). Additionally, AD S. aureus+ patients had significantly greater allergen sensitization (Phadiatop and tIgE), barrier dysfunction (TEWL and stratum corneum integrity), and serum lactate dehydrogenase (LDH) than both the AD S. aureus- and NA S. aureus- groups. FLG mutations did not associate with S. aureus+ colonization. In conclusion, adult patients with AD who are colonized on their skin with S. aureus have more severe disease, greater type 2 immune deviation, allergen sensitization, barrier disruption, and LDH level elevation than noncolonized patients with AD.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors state no conflict of interest.
Figures




Similar articles
-
Temporal variation of Staphylococcus aureus clonal complexes in atopic dermatitis: a follow-up study.Br J Dermatol. 2019 Jan;180(1):181-186. doi: 10.1111/bjd.17033. Epub 2018 Oct 10. Br J Dermatol. 2019. PMID: 30070683
-
Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations.Br J Dermatol. 2017 Nov;177(5):1394-1400. doi: 10.1111/bjd.15470. Epub 2017 Sep 24. Br J Dermatol. 2017. PMID: 28317091
-
Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.Br J Dermatol. 2006 Oct;155(4):680-7. doi: 10.1111/j.1365-2133.2006.07410.x. Br J Dermatol. 2006. PMID: 16965415 Clinical Trial.
-
Endotypes of atopic dermatitis and food allergy.J Allergy Clin Immunol. 2023 Jan;151(1):26-28. doi: 10.1016/j.jaci.2022.07.021. Epub 2022 Aug 30. J Allergy Clin Immunol. 2023. PMID: 36050129 Review.
-
Skin Microbiome in Atopic Dermatitis.Acta Derm Venereol. 2020 Jun 9;100(12):adv00164. doi: 10.2340/00015555-3514. Acta Derm Venereol. 2020. PMID: 32419029 Free PMC article. Review.
Cited by
-
Which Way Do We Go? Complex Interactions in Atopic Dermatitis Pathogenesis.J Invest Dermatol. 2021 Feb;141(2):274-284. doi: 10.1016/j.jid.2020.07.006. Epub 2020 Sep 15. J Invest Dermatol. 2021. PMID: 32943210 Free PMC article. Review.
-
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis.Paediatr Drugs. 2023 Jan;25(1):67-77. doi: 10.1007/s40272-022-00553-8. Epub 2022 Dec 19. Paediatr Drugs. 2023. PMID: 36529811 Free PMC article. Clinical Trial.
-
Specific T cells targeting Staphylococcus aureus fibronectin-binding protein 1 induce a type 2/type 1 inflammatory response in sensitized atopic dermatitis patients.Allergy. 2022 Apr;77(4):1245-1253. doi: 10.1111/all.15120. Epub 2021 Oct 22. Allergy. 2022. PMID: 34601735 Free PMC article.
-
Staphylococcal Communities on Skin Are Associated with Atopic Dermatitis and Disease Severity.Microorganisms. 2021 Feb 19;9(2):432. doi: 10.3390/microorganisms9020432. Microorganisms. 2021. PMID: 33669791 Free PMC article.
-
Microbial derived antimicrobial peptides as potential therapeutics in atopic dermatitis.Front Immunol. 2023 Jan 25;14:1125635. doi: 10.3389/fimmu.2023.1125635. eCollection 2023. Front Immunol. 2023. PMID: 36761743 Free PMC article.
References
-
- Alsterholm M, Strombeck L, Ljung A, Karami N, Widjestam J, Gillstedt M, et al. Variation in Staphylococcus aureus Colonization in Relation to Disease Severity in Adults with Atopic Dermatitis during a Five-month Follow-up. Acta Derm Venereol. 2017;97:802–7. - PubMed
-
- Beck LA, Thaci D, Hamilton JD, Graham NM, Bieber T, Rocklin R, et al. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis. N Engl J Med. 2014;371(2):130–9. - PubMed
-
- Birnie AJ, Bath-Hextall FJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev. 2008:Cd003871. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous